Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
Eastern Cooperative Oncology Group
Rutgers, The State University of New Jersey
G1 Therapeutics, Inc.
European Organisation for Research and Treatment of Cancer - EORTC
Massachusetts General Hospital
Assistance Publique - Hôpitaux de Paris
Radiation Therapy Oncology Group
Seoul National University Hospital
University of Texas at Austin
Avelas Biosciences, Inc.
GBG Forschungs GmbH
Centre Leon Berard
Case Comprehensive Cancer Center
GBG Forschungs GmbH
Abramson Cancer Center at Penn Medicine
American College of Radiology Imaging Network
University of Alabama at Birmingham
ETOP IBCSG Partners Foundation
Masonic Cancer Center, University of Minnesota
Institut du Cancer de Montpellier - Val d'Aurelle
GBG Forschungs GmbH
City of Hope Medical Center
RenJi Hospital
Novartis
Barbara Ann Karmanos Cancer Institute
GBG Forschungs GmbH
SWOG Cancer Research Network
Case Comprehensive Cancer Center
Intarcia Therapeutics
ARCAGY/ GINECO GROUP
University of California, San Francisco
Radiation Therapy Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Cytori Therapeutics